Federal inspectors found that Arbors at Delaware failed to ensure Resident #93 received adequate medications during discharge on February 27, despite the facility having sufficient supplies on hand. The patient, who suffered from intractable epilepsy with status epilepticus, severe intellectual disabilities, and other complex conditions, needed zonisamide twice daily to prevent life-threatening seizures.
The medication shortage created a dangerous gap. With only nine capsules sent home and a follow-up appointment not scheduled until March 5, the resident faced potential seizure complications from insufficient medication supply.
Licensed Practical Nurse Unit Manager #183 told inspectors she removed medications from the resident's designated slot in the medication cart but overlooked additional supplies stored in the overflow area. She admitted sending home only nine capsules of zonisamide 100 mg and two tablets of midodrine, a blood pressure medication.
"There may have been more medications in the overflow area in the cart and she overlooked them," the nurse manager acknowledged during the November 26 interview.
Pharmacy records revealed the facility's substantial medication inventory for this resident. Between January and February, the nursing home received multiple deliveries: 120 capsules on January 5, another 120 on February 21, and 56 more on February 23. For midodrine, deliveries included 30 tablets on January 5, 90 tablets on January 23, and 90 additional tablets on February 16.
The resident's prescribed regimen required significant daily medication consumption. Physician orders called for zonisamide 100 mg, two capsules twice daily, totaling four capsules per day. The midodrine prescription required 10 mg three times daily.
Administration records showed consistent medication use throughout the stay. In January, the resident received 84 capsules of zonisamide and 24 tablets of midodrine. February consumption increased to 102 capsules of zonisamide and 76 tablets of midodrine, reflecting the resident's medical needs during the 54-day stay.
The discharge process failed multiple checkpoints. Facility policy required medication reconciliation upon discharge, including verification of all pre-discharge medications against post-discharge needs. The policy specifically mandated providing adequate medication supplies to receiving care providers.
The resident's discharge plan anticipated return to family care with community support services. The care plan, dated January 5, emphasized involving specialized home care agencies and providing written discharge instructions for safe community transition. A primary physician appointment was scheduled for March 5 at 8:45 AM.
The nurse manager confirmed she never contacted the resident's pharmacy to arrange additional medication supplies or coordinate continued care. This omission left the family responsible for securing seizure medications during a critical transition period.
Pharmacy return records exposed the extent of overlooked medications. On March 10, eleven days after discharge, the facility returned 120 capsules each of zonisamide and midodrine to the pharmacy. These medications could have prevented the dangerous shortage if properly identified during discharge preparation.
The resident's medical complexity amplified the discharge failure's severity. Beyond epilepsy, diagnoses included post-traumatic stress disorder, bipolar disorder, and conversion disorder with seizures. The discharge assessment noted cognitive intactness without behavioral issues, suggesting the resident understood medication importance.
Seizure medications require careful management to prevent breakthrough episodes. Zonisamide, the resident's prescribed anticonvulsant, helps control seizures in patients with treatment-resistant epilepsy. Sudden discontinuation or inadequate dosing can trigger dangerous seizure activity, particularly in patients with status epilepticus history.
The midodrine shortage posed additional risks. This medication treats hypotension by increasing blood pressure, preventing dangerous drops that could cause fainting or falls. With only two tablets provided, the resident faced potential cardiovascular complications within days of discharge.
Federal inspectors classified this violation under regulations requiring safe transfer and discharge procedures. The deficiency affected one of two residents reviewed for discharge practices, suggesting broader systemic issues in medication management during transitions.
The facility's census stood at 89 residents during the inspection period. This single case represented a failure in fundamental discharge protocols that could affect any resident transitioning to home care.
The investigation stemmed from Complaint Number 1369970, indicating external concerns about discharge practices prompted federal scrutiny. Inspectors found minimal harm or potential for actual harm, affecting few residents, but the violation exposed dangerous gaps in medication continuity.
The nurse manager's admission revealed inadequate discharge procedures. Her failure to systematically check all medication storage areas before discharge created preventable risks for a vulnerable resident with life-threatening conditions.
The resident's family faced an immediate crisis upon arriving home. With insufficient seizure medication and no pharmacy coordination, they bore responsibility for preventing medical emergencies during the transition period. The scheduled March 5 physician appointment provided some safety net, but the medication gap remained dangerous.
This case illustrated broader challenges in nursing home discharge planning. Complex residents with multiple medications require systematic verification of all supplies before departure. The facility's policy recognized this need but implementation failed at the critical moment.
The returned medications on March 10 provided stark evidence of the system failure. While the resident struggled with inadequate supplies at home, 240 capsules and tablets sat unused at the facility, eventually requiring return to the pharmacy rather than supporting patient care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Arbors At Delaware from 2025-11-26 including all violations, facility responses, and corrective action plans.